Outcome of acute fulminant myocarditis in children

Heart

Volumn 92, Issue 9, 2006, Pages 1269-1273

  Amabile, N ^a   Fraisse, Alain ^a   Bouvenot, J ^b   Chetaille, P ^a   Ovaert, C ^a  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; CAPTOPRIL; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; DOPEXAMINE; FUROSEMIDE; HEPARIN; IMMUNOGLOBULIN; MILRINONE; PREDNISONE; PROPRANOLOL; SPIRONOLACTONE;

ACUTE FULMINANT MYOCARDITIS; ACUTE HEART FAILURE; ARTICLE; ARTIFICIAL VENTILATION; CARDIOMYOPATHY; CARDIOPULMONARY INSUFFICIENCY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COXSACKIE VIRUS; DOSE RESPONSE; ECHOCARDIOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFANT; INTENSIVE CARE UNIT; MALE; MYOCARDITIS; NEWBORN; OUTCOME ASSESSMENT; PARVOVIRUS; PRIORITY JOURNAL; THROMBUS; VARICELLA ZOSTER VIRUS;

ACUTE DISEASE; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MYOCARDITIS; PROGNOSIS; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT; VIRUS DISEASES;

EID: 33748090248     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.078402     Document Type: Article

References (28)

1. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
2. Lieberman EB, Hutchins GM, Herskowitz A, et al. Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991;18:1617-26.
3. McCarthy RE 3rd, Boehmer JP, Hruban RH, et al., Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5.
4. O'Connell JB, Dec GW, Goldenberg IF, et al. Results of heart transplantation for active lymphocytic myocarditis. J Heart Transplant 1990;9:351-5.
5. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcomes of acute myocarditis in childhood. Heart 1999;82:226-33.
6. Duncan BW, Bohn DJ, Atz AM, et al. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001;122:440-8.
7. Gagliardi MG, Bevilacqua M, Squitieri C, et al. Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates. J Heart Lung Transplant 1993;12:S224-9.
8. Drucker NA, Colan SD, Lewis AB, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994;89:252-7.
9. Matitiau A, Perez-Atayde A, Sanders SP, et al. Infantile dilated cardiomyopathy: relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 1994;90:1310-8.
10. Kleinert S, Weintraub RG, Wilkinson JL, et al. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997;16:1248-54.
11. Calabrese F, Rigo E, Milanesi O, et al. Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol 2002;11:212-21.
12. Ahdoot J, Galindo A, Alejos JC, et al. Use of OKT3 for acute myocarditis in infants and children. J Heart Lung Transplant 2000;19:1118-21.
13. Bowles NE, Vallejo J. Viral causes of cardiac inflammation. Curr Opin Cardiol 2003;18:182-8.
14. Grogan M, Redfield MM, Bailey KR, et al. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995;26:80-4.
15. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001;104:1076-82.
16. Gorg A, Shiau J, Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 1998;129:317-22.
17. Levi D, Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol 2001;16:77-83.
18. Camargo PR, Snitcowsky R, da Luz PL, et al. Favourable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995;16:61-8.
19. Stiller B, Dahnert I, Weng YG, et al. Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart 1999;82:237-40.
20. Acker MA. Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann Thorac Surg 2001;71(Suppl 3):S73-6.
21. English RF, Janosky JE, Ettedgui JA, et al. Outcomes for children with acute myocarditis. Cardiol Young 2004;14:488-93.
22. Fraisse A, Paut O, Zandotti C, et al. Epstein-Barr virus: an unusual cause of acute myocarditis in children. Arch Pediatr 2000;7:752-5.
23. Sluysmans T, Colan SD. Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol 2004;0:1144-2004.
24. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
25. Pophal SG, Sigfusson G, Booth KL, et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999;34:2105-10.
26. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction, evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003;42:466-72.
27. Vallejo J, Mann DL. Antiinflammatory therapy in myocarditis. Curr Opin Cardiol 2003;18:189-93.
28. Bonnet D, de Lonlay P, Gautier I, et al. Efficiency of metabolic screening in childhood cardiomyopathies. Eur Heart J 1998;19:790-3.